Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Hayes

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Nature Medicine|October 9, 2019
Safety profile of autologous macrophage therapy for liver cirrhosisFrancesca Moroni, Benjamin J Dwyer, Catriona Graham, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2023
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant dataCàndid Villanueva, Victor Sapena, Gin-Ho Lo, et al.
Gastroenterology|June 21, 2020
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1Hamish Innes, Stephan Buch, Sharon Hutchinson, et al.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Gastroenterology|July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External ValidationScott Silvey, Patrick S Kamath, Jacob George, et al.
Gut|June 5, 2026
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspectiveFlorence Wong, Danielle Adebayo, Jacob George, et al.
The American Journal of Gastroenterology|April 27, 2026
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis CohortScott Silvey, Ashok K Choudhury, Patrick S Kamath, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Nature Medicine|October 9, 2019
Safety profile of autologous macrophage therapy for liver cirrhosisFrancesca Moroni, Benjamin J Dwyer, Catriona Graham, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2023
Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant dataCàndid Villanueva, Victor Sapena, Gin-Ho Lo, et al.
Gastroenterology|June 21, 2020
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1Hamish Innes, Stephan Buch, Sharon Hutchinson, et al.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Gastroenterology|July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External ValidationScott Silvey, Patrick S Kamath, Jacob George, et al.
Gut|June 5, 2026
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspectiveFlorence Wong, Danielle Adebayo, Jacob George, et al.
The American Journal of Gastroenterology|April 27, 2026
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis CohortScott Silvey, Ashok K Choudhury, Patrick S Kamath, et al.
Pageof 17